Yahoo
NasdaqGS - Delayed Quote USD

DexCom, Inc. (DXCM)

87.90 -1.81 (-2.02%)
At close: September 4 at 4:00:01 PM EDT
87.90 0.00 (0.00%)
After hours: September 4 at 7:30:02 PM EDT
Trade DexCom on Coinbase
Chart Range Bar
Loading chart for DXCM

What's happening with DXCM?

48m ago
Powered by Yahoo Scout

DexCom (DXCM) reported strong Q2 results with $1.31 billion in revenue, but issued conservative full-year guidance. Analysts remain optimistic about the company's growth potential, particularly with upcoming Medicare coverage expansion for continuous glucose monitors (CGMs).

Powered by Yahoo Scout
  • Previous Close 89.71
  • Open 88.78
  • Bid 81.52 x 200
  • Ask 95.95 x 200
  • Day's Range 87.65 - 89.00
  • 52 Week Range 54.11 - 92.59
  • Volume 2,266,002
  • Avg. Volume 4,800,955
  • Market Cap (intraday) 33.17B
  • Beta (5Y Monthly) 1.42
  • PE Ratio (TTM) 34.74
  • EPS (TTM) 2.53
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 94.12

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

www.dexcom.com

11,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DXCM
32.44%
S&P 500 (^GSPC)
12.75%

1-Year Return

DXCM
8.84%
S&P 500 (^GSPC)
18.71%

3-Year Return

DXCM
13.74%
S&P 500 (^GSPC)
70.93%

5-Year Return

DXCM
35.18%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.31B
Earnings 249.1M
Profit Margin 19.04%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
18.0%
20.0%
22.0%

Analyst Insights

View More

Top Analyst

B of A Securities
75/100
Latest Rating
Buy

Analyst Price Targets

79.00 Low
94.12 Average
87.90 Current
115.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/4/2026
Analyst Argus Research
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 86 -> 96

Statistics

View More

Valuation Measures

Annual
As of 9/3/2026
  • Market Cap

    33.85B

  • Enterprise Value

    33.30B

  • Trailing P/E

    35.46

  • Forward P/E

    28.90

  • PEG Ratio (5yr expected)

    1.38

  • Price/Sales (ttm)

    7.18

  • Price/Book (mrq)

    12.91

  • Enterprise Value/Revenue

    6.70

  • Enterprise Value/EBITDA

    21.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.12%

  • Return on Assets (ttm)

    10.33%

  • Return on Equity (ttm)

    38.49%

  • Revenue (ttm)

    4.97B

  • Net Income Avi to Common (ttm)

    999.7M

  • Diluted EPS (ttm)

    2.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.95B

  • Total Debt/Equity (mrq)

    53.35%

  • Levered Free Cash Flow (ttm)

    1.02B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

87.90 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $26.00

    TRUPANION INC has an Investment Rating of HOLD; a target price of $26.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $33.00

    TRUPANION INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $31.00

    TRUPANION INC has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $32.00

    TRUPANION INC has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: